Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The First Phase of the Closed-loop Improvement Project for Preventing CLABSI

NCT07255105 is registered in ClinicalTrials.gov with Jianfeng Xie as lead sponsor.

NCT NCT07255105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07255105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The First Phase of the Closed-loop Improvement Project for Preventing CLABSI
Lead sponsor
Jianfeng Xie
Phase
Observational
Overall status
Recruiting
Start date
June 8, 2025
Completion date
September 30, 2026
Enrollment
1,846 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clabsi - central line associated bloodstream infection